Page 1912 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Index 1339

in ARDS and outcomes, 477, 477t, 478t Fever(s) Fluids
in burn patients, 1182 alkhurma hemorrhagic, 738 role of, in shock, 263
candidates for, for respiratory failure, antipyretic drugs for, 561 sickle cell disease and, 912
472–473, 472t Argentine hemorrhagic, 739 Fluid therapy
complications related to, 476, 476t, 477t blackwater, 728 in establishing effective circulating
goal of, 470 Bolivian hemorrhagic, 739 volumes, 314–315
guidelines for, 481 Brazilian hemorrhagic, 739–740 for sepsis, 570–572, 571t
initiation of, 473–476, 473f, 474f, 476f, 477f Chapare hemorrhagic, 739 Flumazenil, 1197, 1210–1211
outcomes in ARDS, 478 cooling in treating, 561 Fluoroquinolones, 548t, 549, 550
parameters for, 475 Crimean Congo hemorrhagic, for febrile neutropenic patients, 611–612
for pulmonary emboli, 481 718, 740–741 Fluorouracil, 896–897
respiratory conditions requiring, 470, 471t Dengue, 717–718, 734, 736–737 Focal hepatic candidiasis, 618
supportive care on, 475–476 Dengue hemorrhagic, 734, 736–737 Focal neurologic disease, 639–640, 640f
in trauma, 481, 481t drug, 560 Focused Assessment Sonogram in Trauma
2007 influenza A (H1N1) severe ARDS, Ebola hemorrhagic, 740 (FAST), 1157–1158
479–481 hemorrhagic, 743 Focused surveillance, in infection control, 23
use of, 317 with renal syndrome, 742–743 Fomepizole, 1208
veno-arterial, 474 Lassa, 718, 738–739 Fondaparinux, 301
ventilator management during, 475 Lujo virus hemorrhagic, 739 Forced diuresis and urinary pH
weaning of, 476, 476f Marburg hemorrhagic, 740 manipulations, 1204–1205, 1204t
Extrahepatic biliary tract injuries, neutropenic, 606–615 Foreign body embolization, 226
1165–1166 diagnosis of, 606–608, 607t, 608f Foreign body retrieval, intravascular,
Extrathoracic airways, 404 empirical antimicrobial therapy for, 225–226, 225f
Extrathoracic trachea, 404 609–615, 610t, 611t, 614t Fractures
Extravascular lung water, sepsis and, 569 infections and bacterial pathogens acetabular, 1170
Extremity trauma, 1172–1175 causing, 605–606 atlas, 1147
complications in, 1173–1175, 1174f risk assessment in, 608–609 burst, 1147
electrical, 1178 Omsk hemorrhagic, 738 compression, 1147
fracture assessment, 1172, 1173t persistent, 557–562. See also Persistent fever hangman, 1147
treatment of, 1173, 1173t differential diagnosis of fever in ICU, odontoid, 1147
Eye disease, sickle cell disease and, 906 558, 558t rib, 1160
epidemiology and impact of, 557–558 skull, 1122, 1122f
F selected infectious causes of, stabilization of, 1120
Factor Xa inhibitors, 855 558–559 Frank-Starling mechanism, 309
Failed neuromuscular transmission, 485 selected noninfectious causes of Fresh-frozen plasma, 856–857
Family-centered care, 116–120 hyperthermia and, 559–561 Fulminant hepatic failure, 817–818, 817f
high-risk situations for relatives to develop temperature regulation and Functional hemodynamic monitoring, 248
psychological problems, 117 measurement, 557, 557f Functional platelet disorders, 853
measuring quality of critical care treatment of, 561 Fungal infections, 643–651, 1303–1304
experience, 117, 118t Q, 751 clinical disease caused by Candida species,
psychological burden of critical care on Rift Valley, 718, 741 644–645, 644t
patients’ relatives, 117 Rocky Mountain spotted, 676, deep fungal, 1303–1304, 1303f, 1304t
strategies for preventing psychological 718–719, 1299 diagnosis of, 645–647, 645ft, 646f
stress and damage, 117–119, 119t South American hemorrhagic, 739 disseminated candidiasis, 1303
treating family conferences like systemic lupus erythematosus and, 1242 epidemiology of, 643–644, 644t
procedures, 119–120 Venezuelan hemorrhagic, 739 in HIV-infected patient, 636
Family conferences, treating, like yellow, 718, 737–738 identifying patients at risk for invasive
procedures, 119 Fiberoptic bronchoscopy, 383–384 candidiasis, 647
Family consent statutes, 127 Fiberoptic intubation, 389–390, 390f outcomes of invasive Candida
Family history, 999 Fibrin degradation products and infections, 645
Family satisfaction in the ICU (FS-ICU) D-dimer, 848 strategies to prevent invasive candidiasis,
instrument, 117 Fibrinolytic therapy, 307 647–648, 647t
Fanconi syndrome, 924–925 Filamentous fungi, 623–624 treatment of, 648–651, 648t
Fat embolism, 335–336, 335t Filoviridae, 740 Fungal laryngotracheitis, 407
clinical manifestations, 335 Fistula
pathophysiology, 335 aortoenteric, 1021 G
prophylaxis and treatment of, 335–336 tracheo-innominate, 395, 400 Gallbladder ablation, 213
Fat embolism syndrome, 1174–1175, 1175t Flail chest, 1157 Gallbladder distension, 559
Febrile neutropenic patients Flaviviridae, 671–672 Gangrene
role of glycopeptides in, 612–613 Fluconazole, 649 gas, 690
Febrile seizures, 781 Fluid responsiveness Meleney, 690, 691
Feeding protocols, 137 dynamic measures to predict, progressive bacterial synergistic, 690
Fenoldopam in acute renal failure, 931 264–265, 264t Gas gangrene, 690
Fentanyl, 151 predicting, 263–265 Gastric acidity as host defense, 704
Fetal oxygen delivery, in pregnancy, Fluid resuscitation, judging adequacy of, Gastric antral vascular ectasia, 223
1255–1256 262–266, 263f, 264t Gastric aspiration, 394

Index.indd 1339 23-01-2015 15:33:52